These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12715075)

  • 1. Dipeptidyl peptidase IV (CD26) activity in the hematopoietic system: differences between the membrane-anchored and the released enzyme activity.
    Pereira DA; Gomes L; El-Cheikh MC; Borojevic R
    Braz J Med Biol Res; 2003 May; 36(5):567-78. PubMed ID: 12715075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity.
    Jacotot E; Callebaut C; Blanco J; Krust B; Neubert K; Barth A; Hovanessian AG
    Eur J Biochem; 1996 Jul; 239(2):248-58. PubMed ID: 8706727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
    Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
    Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl-peptidase IV-beta--further characterization and comparison to dipeptidyl-peptidase IV activity of CD26.
    Blanco J; Nguyen C; Callebaut C; Jacotot E; Krust B; Mazaleyrat JP; Wakselman M; Hovanessian AG
    Eur J Biochem; 1998 Sep; 256(2):369-78. PubMed ID: 9760177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain?
    Iwaki-Egawa S; Watanabe Y; Fujimoto Y
    Immunobiology; 1995 Nov; 194(4-5):429-42. PubMed ID: 8749235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic stimulation by a dipeptidyl peptidase inhibitor reveals a novel regulatory mechanism and therapeutic treatment for blood cell deficiencies.
    Jones B; Adams S; Miller GT; Jesson MI; Watanabe T; Wallner BP
    Blood; 2003 Sep; 102(5):1641-8. PubMed ID: 12738665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD26 modulates nociception in mice via its dipeptidyl-peptidase IV activity.
    Guieu R; Fenouillet E; Devaux C; Fajloun Z; Carrega L; Sabatier JM; Sauze N; Marguet D
    Behav Brain Res; 2006 Jan; 166(2):230-5. PubMed ID: 16154213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The unique properties of dipeptidyl-peptidase IV (DPP IV / CD26) and the therapeutic potential of DPP IV inhibitors.
    Augustyns K; Bal G; Thonus G; Belyaev A; Zhang XM; Bollaert W; Lambeir AM; Durinx C; Goossens F; Haemers A
    Curr Med Chem; 1999 Apr; 6(4):311-27. PubMed ID: 10101215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicolor cytoenzymatic evaluation of dipeptidyl peptidase IV (CD26) function in normal and neoplastic human T-lymphocyte populations.
    Ruiz P; Zacharievich N; Shenkin M
    Clin Diagn Lab Immunol; 1998 May; 5(3):362-8. PubMed ID: 9605992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CD26/dipeptidyl peptidase IV mRNA level in peripheral blood mononuclear cells with disease activity and bone erosion in rheumatoid arthritis.
    Yeganeh F; Mousavi SMJ; Hosseinzadeh-Sarband S; Ahmadzadeh A; Bahrami-Motlagh H; Hoseini MHM; Sattari M; Sohrabi MR; Pouriran R; Dehghan P
    Clin Rheumatol; 2018 Dec; 37(12):3183-3190. PubMed ID: 30136129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in experimental liver cirrhosis.
    Lakatos PL; Firneisz G; Borcsiczky D; Zalatnai A; Selmeci L; Szalay F
    Eur J Clin Invest; 2000 Sep; 30(9):793-7. PubMed ID: 10998079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of CD26-deficiency on dipeptidyl peptidase 8 and 9 expression profiles in a mouse model of Crohn's disease.
    Buljevic S; Detel D; Pugel EP; Varljen J
    J Cell Biochem; 2018 Aug; 119(8):6743-6755. PubMed ID: 29693275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA synthesis in cultured human keratinocytes and HaCaT keratinocytes is reduced by specific inhibition of dipeptidyl peptidase IV (CD26) enzymatic activity.
    Vetter R; Reinhold D; Bühling F; Lendeckel U; Born I; Faust J; Neubert K; Ansorge S; Gollnick H
    Adv Exp Med Biol; 2000; 477():167-71. PubMed ID: 10849744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo inhibition of dipeptidyl peptidase IV activity by pro-pro-diphenyl-phosphonate (Prodipine).
    De Meester I; Belyaev A; Lambeir AM; De Meyer GR; Van Osselaer N; Haemers A; Scharpé S
    Biochem Pharmacol; 1997 Jul; 54(1):173-9. PubMed ID: 9296364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells.
    Christopherson KW; Hangoc G; Broxmeyer HE
    J Immunol; 2002 Dec; 169(12):7000-8. PubMed ID: 12471135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SDF-1 (CXCL12) in haematopoiesis and leukaemia: impact of DPP IV/CD26.
    Hildebrandt M; Schabath R
    Front Biosci; 2008 Jan; 13():1774-9. PubMed ID: 17981666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further characterization of DPP IV-beta, a novel cell surface expressed protein with dipeptidyl peptidase activity.
    Blanco J; Jacotot E; Callebaut C; Krust B; Hovanessian AG
    Adv Exp Med Biol; 1997; 421():193-9. PubMed ID: 9330697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of immobilized adenosine deaminase (EC 3.5.4.4) for the rapid purification of native human CD26/dipeptidyl peptidase IV (EC 3.4.14.5).
    de Meester I; Vanhoof G; Lambeir AM; Scharpé S
    J Immunol Methods; 1996 Jan; 189(1):99-105. PubMed ID: 8576585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)).
    Balzarini J; Andersson E; Schols D; Proost P; Van Damme J; Svennerholm B; Horal P; Vahlne A
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1848-59. PubMed ID: 15183349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26.
    Marguet D; Baggio L; Kobayashi T; Bernard AM; Pierres M; Nielsen PF; Ribel U; Watanabe T; Drucker DJ; Wagtmann N
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6874-9. PubMed ID: 10823914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.